Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intraflagellar transport protein 74 homolog (IFT74) is a core component of the IFT-B complex, essential for the assembly and function of motile and primary cilia. IFT74, often forming a heterodimer with IFT81, facilitates the binding and transport of tubulin and other cargo along axonemal microtubules for ciliogenesis. Mutations in IFT74 are implicated in a range of ciliopathies affecting development, organ function, and ciliary motility, including Joubert syndrome, Bardet–Biedl syndrome, and certain neurodegenerative disorders[1][2][4][3][6]. IFT74 is not considered a traditional drug target but is a vital structural and functional player in cellular ciliary biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intraflagellar transport protein 74 homolog (IFT74).